**Core Concept**
The risk of endometrial cancer is influenced by various factors, including hormonal, genetic, and anatomical factors. The condition is often linked to unopposed estrogen exposure, which can cause endometrial hyperplasia and increase the risk of cancerous transformation.

**Why the Correct Answer is Right**
The correct answer is associated with a lower risk of endometrial cancer due to the absence of unopposed estrogen exposure. This is because the presence of progesterone counteracts the proliferative effects of estrogen, thereby preventing endometrial hyperplasia. In this case, the presence of progesterone in the form of a progestin-only pill or an intrauterine device (IUD) that releases progestin helps to maintain a balance between estrogen and progesterone levels, thereby reducing the risk of endometrial cancer.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is associated with an increased risk of endometrial cancer due to unopposed estrogen exposure, which can lead to endometrial hyperplasia and cancerous transformation.
**Option B:** This option is also associated with an increased risk of endometrial cancer due to the absence of progesterone, which can allow unopposed estrogen to promote endometrial hyperplasia.
**Option C:** This option is associated with an increased risk of endometrial cancer due to the presence of unopposed estrogen, which can lead to endometrial hyperplasia and cancerous transformation.

**Clinical Pearl / High-Yield Fact**
It's essential to note that the risk of endometrial cancer can be reduced by using progestin-only methods of contraception, such as the progestin-only pill or an intrauterine device (IUD) that releases progestin.

**Correct Answer: D. Progestin-only pill or IUD releasing progestin.**